A recent study reveals that smoking before age 15 significantly raises the risk of developing COPD later in life, even if a ...

Individuals with early-onset COPD and rapidly progressive pre-COPD frequently have a decades-long history of impaired ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive ...

Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...

The Texas Tech University Health Sciences Center is offering a new treatment for patients suffering from severe chronic ...

The Ministry of Public health (MoPH) is intensifying efforts to raise awareness about asthma and chronic obstructive ...

Verona Pharma’s Ohtuvayre has a solid market entry, but its valuation is high. Read why VRNA stock remains a buy for ...

Benralizumab is more effective than prednisolone in treating eosinophilic exacerbations in patients with asthma and COPD.

Childhood smoking before age 15 increases a person's risk of developing chronic obstructive pulmonary disease (COPD), ...

A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...